Many safe and effective OTC ophthalmic drugs or products from artificial tears and ointments to ocular decongestants for mild eye disorders are available for self-treatment. Many common eye (ocular) disorders disappear without treatment or can be managed by self-treating. Some of the prescription medications for eye allergy include eyedrops (decongestant, antihistamine, mast cell stabilizer, corticosteroid, NSAID). allergy shots (immunotherapy), and non-sedating oral antihistamines; while over the counter medication includes artificial tears, decongestant eyedrops, and oral antihistamines. Treatments for dry eye syndrome include artificial tears, gels, or ointments; corticosteroid drops; cyclosporine A drops; and punctal plugs. Supportive therapies to treat underlying causes of dry eye, such as meibomian gland dysfunction, include hot compresses, lid scrubs, and omega-3 supplements. Although there is no cure for glaucoma, IOP-lowering eye drops are the current treatment strategy for most types of the disease. Corticosteroids are currently the only drugs in the United States approved for treating retinal disorders such as non-infectious uveitis, although their long-term use leads to side effects.
The global ophthalmic drugs market segmentation is based on disease type (allergy, dry eye disorder, glaucoma, retinal disorder), and dispense type (over-the-counter, prescription).
The global ophthalmic drugs market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global ophthalmic drugs market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World. The global ophthalmic drugs market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global ophthalmic drugs market and profiled in this report include Abbott Healthcare, Allergan Plc, Bayer, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer, Inc., Renegeron, Santen Pharmaceuticals Company Ltd., and Valeant Pharmaceuticals, Inc.